The Middle East conflict is not Venezuela, or Russia’s invasion of Ukraine, or COVID. Policymakers should not use “the last war” as a template for the current one. The Middle East conflict and the resulting Read more…
Key insights from the week that was. In Australia, February’s CPI came in slightly below expectations, headline inflation ticking down to 3.7%yr from 3.8%yr, while trimmed mean inflation held steady at 3.3%yr. Constructive elements of Read more…
The dollar kept firm tone and rose further against its major counterparts on Thursday, following rise in oil prices (Brent bounces back above $100) that sparked fresh wave of risk aversion and fueled demand for Read more…
Jeff Currie could pass as a preacher. But you may not like what he’s preaching. The partner of the Carlyle Group and head of its Energy Pathways Group thinks oil prices have not yet peaked Read more…
GBP/USD is under pressure due to cautious market sentiment, USD strength stemming from Middle East ceasefire strains, and uncertainty following President Trump’s delay of Iran’s energy plant destruction. Technical analysis reveals a bull flag pattern Read more…
It is a year of pump-fakes for all asset classes, and Cryptocurrencies could not sustain the pressure. Just last week, one could have imagined that Cryptos were isolated from the anxiety dampening global assets – Read more…
DAX: ⬇️ Sell DAX reversed from resistance level 23000.00 Likely to fall to support level 21875.00 DAX index recently reversed from the resistance zone between the resistance level 23000.00 (former support from June and November), Read more…
Oil prices are surging on the back of the Iran war. Fears of a sustained disruption to Strait of Hormuz supply are driving the move. The parallels to the 1970s oil crises are everywhere. But Read more…
Few brands are as deeply embedded in youth culture as one that helped define the style identities of multiple generations, and whose site evokes nostalgia in many shoppers. From its expansive selection of Vans sneakers Read more…
Hims & Hers (HIMS) has taken a beating, with the stock down roughly 70% from its $70 peak and now trading below $21 per share. But the story’s changing. After the company’s Novo Nordisk (NVO) Read more…